Ipamorelin mastery course
Unit 5 of 11

The CJC-1295 stack

Ipamorelin is rarely used alone. The dominant community protocol pairs it with CJC-1295, and that pairing is not arbitr…

Why ipamorelin is almost always paired

Ipamorelin is rarely used alone. The dominant community protocol pairs it with CJC-1295, and that pairing is not arbitrary: it rests on one of the better-established two-receptor interactions in human endocrinology. Pressing the GHRH pathway and the GHS pathway together produces a GH pulse larger than the sum of each alone.

This unit explains the pharmacology of that synergy, the important difference between the no-DAC and DAC versions of CJC-1295, why pulsatility is the whole argument, and how to read stack claims honestly, because a sound mechanism still does not equal a measured clinical outcome.

Key terms

Two pathways, one pulse


How big is the synergy


No-DAC versus DAC


Why pulsatility is the argument


What the stack evidence supports


Reading stack claims critically